Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Article · Originalarbeit

Editor's Choice - Free Access

Traditional Chinese Medicine in Cancer Care: A Review of Case Reports Published in Chinese Literature

Liu J.a,b · Li X.b · Liu J.b · Ma L.b · Li X.b · Fønnebø V.a

Author affiliations

a National Research Center in Complementary and Alternative Medicine (NAFKAM), University of Tromsø, Norway, b Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China

Corresponding Author

Jianping Liu, M.D., Ph.D., National Research Center in Complementary and Alternative Medicine (NAFKAM), University of Tromsø, Tromsø, 9037, Norway, Tel. +47 7764-6650, Fax -6866, jianping.liu@uit.no

Related Articles for ""

Forsch Komplementmed 2011;18:257–263

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Background: Traditional Chinese Medicine (TCM) is widely used for cancer treatment in China. Many support its use in treatment for cancer, yet scientific evidence for the effect of TCM needs to be established. Material and Methods: In this review case reports on cancer patients treated by TCM therapies are included. Search runs were conducted in 4 main Chinese databases till December 2009. Results: A total of 716 reports involving 1,198 cancer patients were identified and summarized. Top 5 of the reported cancers treated with TCM were lung cancer (14.44%; 173 patients), leukemia (14.11%; 169 patients), stomach cancer (10.85%; 130 patients), liver cancer (10.18%; 122 patients) and esophageal cancer (7.35%; 88 patients). In the majority of cases (66.44%; 772) combined treatments of Chinese and conventional medicine were applied. The use of herbal medicine was highly prevalent (98.50%; 1,168 patients), and the typical administration was an individually tailored treatment according to the pattern differentiation of symptoms (74.21%; 889 patients); the use of acupuncture was relatively rare (1.8%; 22 patients). Symptom improvement was the most frequently reported outcome (84.72%; 1,015 patients). Only 15 studies (2.1%) were structurally reported. Detailed information on patients’ demography, pathologically confirmed diagnosis and safety was given in 275 (22.95%), 692 (57.76%) and 10 (0.83%) reports, respectively. Conclusion: The amount of information from case reports of TCM therapies in cancer is rich and can be valuable for the preliminary evaluation of TCM and for the planning of further clinical trials in cancer treatment. However, the quality of the reports was generally poor and we recommend that case reports should be published in a structured manner.

© 2011 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: October 04, 2011
Issue release date: October 2011

ISSN: 2504-2092 (Print)
eISSN: 2504-2106 (Online)

For additional information: http://www.karger.com/CMR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.